Latest news
LivaNova reports Q2 2026: Revenue $390.6M, adjusted EPS $1.26; raises full-year guidance - TradingViewTradingView · Wed, 05 Aug 2026 10:13:01 GMTAdaptHealth reports Q2 revenue $740.3M, adjusted EBITDA $132.0M; goodwill impairment drives loss - TradingViewTradingView · Tue, 04 Aug 2026 11:13:01 GMTApnimed, Developer of Oral Therapies for Obstructive Sleep Apnea, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 31 Jul 2026 20:09:00 GMTResmed's Q4 Earnings on Deck: What's in Store for the Stock? - TradingViewTradingView · Fri, 31 Jul 2026 13:32:00 GMTApnimed Announces Pricing of Upsized Initial Public Offering - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTEnterprise value to EBIT forward of OSAI Automation System SpA – MIL:OSA - TradingViewTradingView · Thu, 30 Jul 2026 06:35:35 GMTSleep apnea pill developer Apnimed targets $608 million valuation in US IPO - TradingViewTradingView · Mon, 27 Jul 2026 07:00:00 GMT